Bio-Rad Laboratories Inc - Class A
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B) is a leader in developing, manufacturing, and marketing a broad range of products for the life science research and clinical diagnostics markets. Based in Hercules, California, Bio-Rad operates a global network of research, development, manufacturing, and sales operations with approximately 7,700 employees, and $2.6 billion in revenues in 2024. Our customers include universities, research institutions, hospitals, and biopharmaceutical companies, as well as clinical, food safety and environmental quality laboratories. Together, we develop innovative, high-quality products that advance science and save lives.
Earnings per share grew at a -13.1% CAGR.
Current Price
$292.23
+1.41%GoodMoat Value
$938.27
221.1% undervaluedBio-Rad Laboratories Inc - Class A (BIO) Social Sentiment
BIO Social Sentiment Analysis
Social media sentiment analysis for Bio-Rad Laboratories Inc - Class A (BIO). Track bullish and bearish sentiment, mention volume, and BuzzScore trends from StockTwits and Reddit. Social sentiment provides a crowd-sourced view of investor confidence in BIO.
Current stock price: $292.23. Market cap: $7.88B. This page displays sentiment timelines, bullish vs bearish ratios, total mention counts, peak BuzzScore data, and source breakdowns for BIO. The sentiment data is updated regularly to reflect the latest social media activity.
Social sentiment is one of many signals to consider when evaluating a stock. High bullish sentiment combined with strong fundamentals may reinforce a buy thesis. Use GoodMoat's sentiment tracking alongside quality analysis, financial data, and valuation models to make well-informed investment decisions about Bio-Rad Laboratories Inc - Class A.